About the Authors
- Chao Zhang
-
Contributed equally to this work with: Chao Zhang, Na Yang
Affiliation Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Na Yang
-
Contributed equally to this work with: Chao Zhang, Na Yang
Affiliation Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Chun-hao Yang
-
Affiliation Division of Organic Synthesis, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Hua-sheng Ding
-
Affiliation Division of Organic Synthesis, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Cheng Luo
-
Affiliation Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Yu Zhang
-
Affiliation Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Mao-jiang Wu
-
Affiliation Division of Organic Synthesis, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Xiong-wen Zhang
-
Affiliation Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Xu Shen
-
Affiliations Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China, School of Pharmacy, East China University of Science and Technology, Shanghai, China
- Hua-liang Jiang
-
Affiliations Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China, School of Pharmacy, East China University of Science and Technology, Shanghai, China
- Ling-hua Meng
-
* E-mail: lhmeng@mail.shcnc.ac.cn (L-hM); jding@mail.shcnc.ac.cn (JD)
Affiliation Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Jian Ding
-
* E-mail: lhmeng@mail.shcnc.ac.cn (L-hM); jding@mail.shcnc.ac.cn (JD)
Affiliation Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: LHM JD. Performed the experiments: CZ NY YZ. Analyzed the data: CZ NY LHM JD. Contributed reagents/materials/analysis tools: CY HsD MjW XWZ XS. Wrote the paper: CZ NY LHM JD. Molecular Modeling: CL HJ.